title: Compassionate and optimum use of new tuberculosis drugs.
authors.affiliation: Inpatient Tuberculosis Unit, Olive View-UCLA Medical Center, Sylmar, CA, USA; David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA, USA.
authors.forename: Caitlin
authors.initials: C
authors.lastname: Reed
authors.affiliation: Inpatient Tuberculosis Unit, Olive View-UCLA Medical Center, Sylmar, CA, USA.
authors.forename: Leona
authors.initials: L
authors.lastname: Mason
authors.affiliation: Medical Microbiology, University of Cape Town, Cape Town, South Africa.
authors.forename: Helen
authors.initials: H
authors.lastname: Cox
authors.affiliation: Heartland National TB Center, Texas Center for Infectious Diseases, San Antonio, TX, USA.
authors.forename: Barbara
authors.initials: B
authors.lastname: Seaworth
authors.affiliation: TB/HIV Project, Treatment Action Group, New York, NY, USA.
authors.forename: Erica
authors.initials: E
authors.lastname: Lessem
authors.affiliation: TB Research Unit, Case Western Reserve University, Cleveland, OH, USA. Electronic address: jjf38@case.edu.
authors.forename: Jennifer
authors.initials: J
authors.lastname: Furin
mesh_terms: D000328:Adult; D000995:Antitubercular Agents / Q000009:adverse effects / Q000627:therapeutic use*; D064687:Diarylquinolines / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination / Q000379:methods; D054908:Extensively Drug-Resistant Tuberculosis / Q000188:drug therapy* / Q000601:surgery*; D006297:Health Services Accessibility; D006801:Humans; D008297:Male; D009593:Nitroimidazoles / Q000009:adverse effects / Q000627:therapeutic use*; D010080:Oxazoles / Q000009:adverse effects / Q000627:therapeutic use*; D011013:Pneumonectomy
chemical_list: D000995:Antitubercular Agents; D064687:Diarylquinolines; D009593:Nitroimidazoles; C516022:OPC-67683; D010080:Oxazoles; C493870:bedaquiline